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Abstract 
Background: The intangible concept of trust is critical in the patient-provider relationship. Cancer patients may experience 
positive and negative impacts of trust in this relationship to a higher degree due to the inherently serious nature of their 
disease and the level of dependence upon treatment providers. 
Objective: The goal of this study was to compare colorectal cancer patients’ levels of trust in their primary care physician and 
oncologist, along with examining trust differences associated with demographics and other characteristics.  
Methods: Colorectal cancer patients (n=158) treated at Nebraska Medicine and consented into the Integrated Cancer 
Repository for Cancer Research IRB 253-13-EP (iCaRe2) database were surveyed. The TiOS instrument measures five 
domains of trust using a 5-point Likert scale. Possible rural and urban differences, as well as other data characteristic 
patterns, were examined using descriptive statistics, frequency analysis, and t-tests. 
Results: There was a measurable difference observed between oncologist and primary care provider (PCP) trust levels for all 
domains (except Competence), with trust in the oncologist reported higher. The overall Global domain measured a higher 
level of patient trust in the oncologist (3.65) compared to the PCP (2.96) with a P-value of 0.003. Due to the small sample 
size, statistical tests were not conducted comparing mean trust between oncologist and PCP within the sociodemographic and 
geographic variables.  
Conclusion: The higher levels of trust reported for four out of five domains suggest that cancer patients feel more trust 
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toward their oncologist than toward their PCP. The difference in trust in the Global domain suggests that cancer patients feel 
a deeper trust in their oncologist that includes aspects of Fidelity, Honesty, and Caring. Future studies should seek to further 
understand the impact of trust in the patient-provider relationship as well as the factors that influence trust. The findings from 
this study contribute to the current knowledge of patient-provider trust in the cancer patient population and provide valuable 
information for future studies. 
Introduction 
Service Learning Organization Site: Nebraska Medicine, Fred and Pamela Buffett Cancer Center 
 The mission of the Fred and Pamela Buffett Cancer Center is to coordinate basic and clinical cancer 
research, provide patient care and educational programs, and facilitate the application of new knowledge about the 
etiology, diagnosis, treatment, and prevention of cancer while improving overall health and quality of life. 
Problem Statement  
Colorectal cancer is the third leading cause of cancer-related deaths in women and the second leading 
cause in men (American Cancer Society, 2018). The American Cancer Society has estimated 97,220 new cases of 
colon cancer and 43,030 new cases of rectal cancer for 2018. Nebraska maintains a large rural population with the 
latest data from the Nebraska Cancer Registry reporting 917 diagnoses of colon and rectal cancer for the entire 
state in 2014 (Nebraska Health and Human Services, 2017). Previous research suggests that patient trust is 
associated with adherence to care plans, desirable treatment outcomes, increased patient satisfaction, and an 
increase in clinical trial participation (Hall et al., 2002; Dugan et al., 2005; Trachtenberg et al., 2005; Nurgat et 
al., 2005). However, patient trust in primary care physicians and oncologists of the colorectal cancer rural 
population within Nebraska has not previously been studied in this way. The patient-provider trust relationship 
should be examined to provide a higher quality of care to cancer patients. 
Importance of Proposed Project 
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Patient trust is an important concept within many areas of healthcare but is especially critical in the cancer 
patient population. This is believed to be due to the extreme vulnerability of these patients as well as the severity 
of their disease (Salkeld et al., 2004). Cancer patients are often required to place all their trust in their physicians 
due to the inability to provide adequate care for themselves. Trust in the patient-provider relationship is fragile 
due to the power inequity between the patient and the provider (Delmar, 2012). It is important to study this 
relationship because patients with higher trust are more likely to report a better quality of health and more 
effective treatment results (Hall et al., 2001). Both rural and urban cancer populations face barriers in screening 
and receiving care, with Nebraska consisting of a large rural population (Jones et al., 2010; Hughes et al., 2015). 
Colorectal cancer patients have several stages of surgery, treatment, and care after diagnosis and require attention 
from an oncologist on a regular basis. Colorectal patients may seek medical or surgical treatment for cancer-
related symptoms from their local primary care provider prior to pursuing care with an oncologist. 
 Literature Review 
Trust is the belief or confidence placed in another person and involves a prediction regarding his or her 
future behavior. Patients are often required to place all of their trust in their physician, a person with whom no 
close relationship exists, due to their inability to care for their own health (Mechanic et al., 2000). Patient’s trust 
in their physicians has been defined as ‘the belief that a doctor is working in the patient's’ best interests’ 
(McKinstry et al., 2006) as well as the optimistic acceptance of the vulnerable situation in which patients believe 
that the physician cares for their interests (Hall et al., 2001). Although trust can be interchanged with confidence, 
trust can often involve higher emotions and is therefore less rational (Hall et al., 2002). Several degrees of trust 
and distrust occur within interpersonal relationships. The concept of distrust is the expectation of negative or 
harmful behaviors and is unique from low trust, which entails the absence of a beneficial action. Considering the 
variations and degrees of trust, it is possible for patients to simultaneously hold a certain amount of trust and a 
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certain amount of distrust toward a physician (Hillen et al., 2011).  
Cancer patients are exceptionally vulnerable due to the inherently life-threatening nature of their disease. 
The severity of the treatment, and frequent low survival rates, may force cancer patients to trust their physicians 
almost unconditionally (Salkeld et al., 2004). Some researchers have proposed that the level of trust that patients 
place in their physicians has a profound effect on care seeking and completion of preventative, diagnostic, 
treatment, and behavioral recommendations (Hall et al., 2001; Berry et al., 2008). In recent studies on patients 
with colorectal cancer (CRC), many have focused on outcomes, side effects, quality of life, and survival (Salkeld 
et al., 2004; Hillen et al., 2011). This suggests that trust plays a role in the interpersonal relationship between 
cancer patients and their providers. 
Recent studies have been initiated to examine the factors relating to and the impact of trust within cancer 
patient populations. One of the theories applied was the attachment theory, a model that attempts to describe the 
dynamics of interpersonal relationships between people. This model specifically focuses on the strong emotional 
and physical attachment that is formed between a patient and caregiver. From an attachment theory perspective, 
levels of trust and distrust do not significantly change over time between three months and nine months after 
diagnosis (Holwerda et al., 2012).  Insecurely attached patients trust their physicians less and are associated with a 
decreased satisfaction in their physician than patients who were securely attached (Holwerda et al., 2012).  
Previous studies have identified trends between levels of trust and a variety of variables. Specific 
populations have been identified to have abnormally higher or lower levels of provider trust. Compared with Non-
Hispanic White patients, Non-Hispanic Black and Hispanic patients report a lower degree of trust with their 
healthcare providers (Halbert et al., 2006; Berrios-Rivera et al., 2006; Bova et al., 2012). In studies examining 
prostate cancer patients, Non-Hispanic Black were found to have greater variability in the levels of patient-
provider trust when compared to Non-Hispanic White patients (Do et al., 2010). 
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 Distrust (the opposite of trust) has been found to have a negative and pervasive impact on health seeking 
behavior (Katapodi et al., 2010). Distrust of the healthcare system has been found to be significantly correlated 
with age in breast cancer patients (Katapodi et al., 2010). Halbert et al., (2009) found that marital status had a 
measurable effect on trust levels among Non-Hispanic White men, with mistrust greater in those that were 
married. Levels of low trust have also been found to be related to fewer quality interactions with providers 
(Halbert et al., 2006).  
There are discrepancies between several studies regarding gender and trust, with both positive and neutral 
relationships reported (Murray et al., 2014). Two studies of patients with rheumatic disease found female gender 
to be related with higher levels of trust (Freburger et al., 2003; Berrios-Rivera et al., 2006). Older age has been 
associated with higher trust in five studies (Weng et al., 2011; O’Mally et al., 2004; Cunningham et al., 2007; 
Kayaniyil et al., 2009) while lower education was also found to be correlated with higher trust (O’Mally et al., 
2004; Kayaniyil et al., 2009).  
Patients with colorectal cancer often rely on a wide range of social support provided by family, friends, 
primary care providers, and cancer specialists (Sahay et al., 2000). Colorectal cancer patients depend upon cancer 
specialists as their primary source of information but rely on family physicians to fill in gaps in understanding and 
provide additional support (Sahay et al., 2000). Rural patients with high levels of trust in their physicians 
occasionally rely entirely on the recommendations made by their primary care physician concerning their 
treatment decisions as opposed to their other treating physicians (Coyne et al., 2004). Previous studies suggest 
that differences in the levels of trust felt by patients for their primary care physicians versus their oncologists may 
vary (Hillen et al., 2011). 
In many qualitative studies, trust was not the initial subject of interest but instead an outcome deduced 
from the data (Hillen et al., 2010). In quantitative studies, trust was incorporated in the research design as one of 
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many variables and as a result has received little conceptual attention (Hillen et al., 2010). Cancer patients may 
feel trust in a different way toward their oncologist than toward their primary care physician due to the unique 
nature of the relationship. Additional research attention is warranted because of the necessity of trust from the 
patient toward the physician due to the life threatening nature of their disease (Hillen et al., 2010). Identifying 
properties and factors of trust for colorectal cancer patients is important considering the severity of the disease 
and the associated dependence that is required from the patient (Hillen et al., 2010; Mechanic et al., 2000). 
Goals and Objectives 
Based on the findings from current literature, there is a need for further research to examine levels of trust 
in cancer patients in Nebraska. Previous studies suggest that oncologists play a different role in patient care than 
primary care physicians, indicating the need to examine possible differences in patient-provider trust. Variations 
in levels of trust between rural patients and urban patients have also been found in other states, indicating that the 
highly rural state of Nebraska may exhibit similar trends. We hypothesize that there will be observable differences 
between survey values in patient-provider trust between primary care physicians and oncologists as well as 
differences across geographic areas. 
The first goal of this study was to measure levels of colorectal cancer patient trust toward both their 
primary care physician and their oncologist. The second goal of this study was to examine characteristics of this 
population and variables that may be associated with trust. These variables and sociodemographic characteristics 
may exert an influence on the patient-provider relationship. 
Research Hypothesis 
I. Examine the relationship of trust within the colorectal cancer patient population in Nebraska. 
A. Compare levels of trust that colorectal cancer patients feel toward their primary care providers 
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and oncologists. 
B. Identify characteristics of this population of cancer patients by demographics and geographic 
area. 
1. Conduct survey of colorectal cancer patients consented into the  iCaRe2 database registry 
using the Trust in Oncologist (TiOS) survey instrument. Examine sociodemographic 
factors of the respondents. 
Research Methods 
Data Source 
This study utilized information that was available from an existing UNMC patient database. Participants 
(age 19+, n=153) were previously recruited into the iCaRe2 database registry (IRB 253-13 EP) with a confirmed 
primary colon, rectal or colorectal diagnosis in the state of Nebraska over the last 10 years. Participants were 
recruited in a prospective fashion (n=5) from the oncology clinic at Nebraska Medicine, resulting in a combined 
retrospective and prospective population. Participants were identified by rural or urban status based on their zip 
code of primary residence using the CDC Urban-Rural Classification Scheme by County published in 2013. For 
consistency, each patient was provided with two copies of the TiOS; 1) to be completed regarding their primary 
care physician, 2) to be completed regarding their oncologist. (See attached TiOS survey instrument in Appendix). 
The iCaRe2 registry database was developed and is governed by the University of Nebraska Medical 
Center to maintain and track cancer patients, patients who are at a high-risk of developing cancer, and healthy 
control individuals. The registry contains patient demographics such as age, gender, and place of residence, as 
well as medical data and socioeconomic characteristics including education and income. The registry collects two 
baseline disease-specific questionnaires at the time of diagnosis to procure additional patient information.  
Study Design 
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This is a cross-sectional, observational study utilizing survey data to assess levels of patient trust. 
Study Population and Sampling 
All participants with a confirmed primary diagnosis of colon or rectal cancer were eligible for this study. 
This included males and females of all races and ethnicities (aged 19+) with a primary colon or rectal diagnosis of 
any stage. No limitations were set regarding dates of diagnosis or medical history. Several participants (n=7) were 
removed from the data set due to ineligibility for a deceased status (n=5) and a decline status (n=1). One patient 
was removed from the study due to an ethical conflict of interest (n=1). Data that could complicate the analytical 
process may include physician communication skills, number of comorbidities, having been in remission, number 
of visits to the physician in the last 12 months, recent metastasis, and age at diagnosis. These factors have been 
previously identified to impact levels of trust and may alter how patients feel about their physicians. Participants 
were emailed a copy of the TiOS questionnaire if a current email address was listed in the medical records. For 
patients without listed email address, a paper version of the TiOS questionnaire was mailed to their residence or 
provided during a clinic visit. All eligible participants (n = 158) were invited to participate in this study. 
Data Collection 
The iCaRe2 department sent an initial point of contact letter (either email or mail) to participants on 
behalf of the Fred and Pamela Buffett Cancer Center and this study. The Trust in Oncologist Scale (TiOS) was 
then distributed either in-person, via email, or by mail to all eligible patients. Participants visiting the oncology 
clinic at the Fred and Pamela Buffett Cancer Center during routine standard care visits were provided with the 
TiOS after consenting into the iCaRe2 registry. Participants consenting in person were provided with the option of 
a paper or online version of the questionnaire for this study, in addition to the iCaRe2 baseline questionnaires at 
time of iCaRe2 consent. The online version of the questionnaire was created using the REDCap software platform 
hosted by Nebraska Medicine. One reminder notice was sent if no response was received within three weeks for 
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mail, and two weeks for email. For emailed participants, if no response was received after one email reminder 
notice, a hard-copy survey was mailed to their residence. 
Measures 
Extensive demographic information has been previously recorded in the registry prior to the start of this 
study. The first iCaRe2 core questionnaire contains socio-demographic factors (age, gender, race, ethnicity, 
chemical exposure, lifestyle factors) while the second extended module questionnaire collects disease specific 
factors, (symptoms, medical history, family medical history, validated quality of life survey - SF-36). (See 
attached iCaRe2 questionnaires in Appendix). Clinical information has previously been collected from the medical 
records and recorded to include primary cancer site, tumor histology, stage, dates of diagnosis and dates of 
treatment.  
To better understand the goals of this study, it is important to be aware of other trust-measuring survey 
instruments. The Trust in Physician Scale (Anderson et al., 1990) was developed to measure patient trust in the 
primary care provider and predates the TiOS. The Patient Trust Scale (Kao et al., 1998) was constructed to 
incorporate changes in the healthcare system, specifically the transition to managed care (Hillen et al., 2013). The 
most recently developed instrument, the Physician Trust Scale (Hall et al., 2002), is currently the most used 
instrument for measuring trust. All three of these instruments were developed in the primary care setting and 
measure reported levels of patient trust toward their primary care physician.  
In contrast, the Trust in Oncologist Scale (TiOS) was created to assess cancer patient satisfaction and trust 
in health care (Hillen et al., 2012). The instrument utilizes the four main domains from the previously validated 
10-item Trust in Physician Scale (Hall et al., 2002) of “competence, fidelity, confidentiality, and honesty”. During 
the development of the TiOS, an additional domain of “caring” was added based on patients’ accounts of trust 
obtained from qualitative research (Hill et al., 2012). This additional domain is important because the existing 
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dimensions did not fully capture patients’ constructions of trust, referring to the oncologist’s expression of 
involvement, sympathy, and attention to the patient. Using the TiOS, an overall trust score can be obtained by 
averaging the responses, with higher scores indicating higher trust. Previous studies have found that patients are 
able to distinguish between the different aspects of trust (domains); this allows for the separate use or 
investigation of one of the specific trust components (Hillen et al., 2012).   
An abbreviated version of the TiOS, the Trust in Oncologist Scale-SF was developed as an effective short 
form version of the scale (Hillen et al., 2017). The TiOS was validated in two studies (first in Dutch and then in 
English) using confirmatory factor analysis, exploratory factor analysis, measurement of internal consistencies, 
and calculation of Spearman’s correlations between the instrument and known correlates. These correlates were 
satisfaction, trust in health care, and number of previous consultations with the oncologist.  
The long-version TiOS uses 18 items to measure a cancer patient’s trust in their oncologist along five 
domains: global, competence, fidelity, honesty, and caring. Internal consistency was assessed with a Chronbach’s 
alpha of .94 (Hillen et al., 2012). All 18 items of the scale consist of a questions using a 5-point Likert answering 
scale (‘strongly disagree’ (1) to ‘strongly agree’ (5) (Hillen et al., 2012). For example, “Your doctor is very 
careful and precise” is a question item measuring the Competence domain. Mean trust (range 1-5) is calculated by 
averaging the responses. Three items are phrased in a negative context to provide reverse-coded questions. In 
addition to the 18-items on the TiOS survey, an open-ended answer box was included on the survey for this study. 
Adding this qualitative measurement allowed patients the opportunity to express concerns not measured by the 
survey and provide additional information for analysis. 
Table 1 shows an overview of all items and dimensions of the TiOS including the means and standard 
deviations of each test item. Table 2 shows the Chronbach’s alpha for each domain within the Trust in Oncologist 
Scale, with an overall (Global) alpha of 0.824. This is considered a good alpha score for the reliability test. 
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Table 1: Overview of all items and dimensions of the Trust in Oncologist Scale (Hillen et al., 2013) with reliability test results. 
Dimension Item Content M SD 
Competence 1 Your doctor is very careful and precise 3.81 0.402 
Competence 6 You think your doctor can handle any medical situation, even a very serious one 3.65 0.562 
Competence 9 Sometimes you worry that your doctor's medical decisions are wrong* 0.54 0.859 
Competence 11 Sometimes your doctor does not pay full attention to what you are trying to tell him/her* 0.69 1.123 
Honesty 2 Your doctor is totally honest in telling you about all the different treatment options available for your condition 3.69 0.549 
Honesty 3 Your doctor always gives you honest information about your prospects 3.62 0.852 
Honesty 12 Your doctor would always tell you the truth about your health, even if there was bad news 3.62 0.637 
Fidelity 4 Your doctor strongly cares for your health 3.85 0.368 
Fidelity 5 Your doctor always tells you everything you want to know about your illness 3.69 0.471 
Fidelity 8 Your doctor explains everything so that you can consent to medical decisions 3.73 0.533 
Fidelity 10 Your doctor only thinks about what is best for you 3.42 0.857 
Fidelity 15 Your doctor will do whatever it takes to get you all the care you need 3.62 0.496 
Caring 7 Your doctor always takes his/her time with you 3.65 0.629 
Caring 13 You have doubts whether your doctor really cares about you as a person* 0.62 1.169 
Caring 14 Your doctor listens with care and concern to all the problems you have 3.69 0.471 
Caring 16 Your doctor is available for you whenever you need him/her 3.31 0.788 
Global Item 17 You have no worries about putting your life in your doctor's hands 3.58 0.902 
Global Item 18 All in all, you have complete trust in your doctor 3.73 0.533 
*Reverse-scored items. Likert scale: 1= totally disagree, 2= disagree, 3= as much agree as disagree, 4= agree, 5= strongly agree 
 
Table 2: Cronbach’s alpha for each domain, including the mean, for the reliability test.  
Domain Mean Cronbach's Alpha 
Honesty 11.5019 0.79 
Competency 12.8689 0.905 
Fidelity 11.5353 0.762 
Caring 12.3112 0.788 
Global 11.6622 0.824 
 
Statistical Analysis 
Central tendency distributions and frequencies were used to examine the study population prior to 
analysis. Survey data was analyzed to study the means of each of the five domains for the survey and compare 
mean trust scores between oncologist and primary care physician groups. Demographics were considered during 
the analysis to identify potential patterns between groups based on age, gender, and geographic location. This is 
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an exploratory study specifically examining patient feelings of trust toward their providers and therefore statistical 
analysis was limited. A larger sample would be necessary to conduct extensive statistical analysis comparing 
geographic regions or levels of trust between population groups. T-tests were used to examine the domains and 
possible differences in the trust scale as well as between demographic and geographic variables. SPSS version 25 
was used for the analysis. 
Results 
An internal reliability test was conducted in SPSS prior to statistical analysis. Internal consistency was 
found to be strong with a Chronbach’s alpha of 0.824. The per-patient status for the initial data collection is 
represented in Table 3. This includes 26 complete responses, 6 partial/incomplete responses, 1 declined response, 
5 deceased after data query, and 1 removed due to a conflict of interest. Table 4 shows variable information for 
complete survey responses. Table 5 represents the statistical values for each domain including the N Statistic 
(number of times the response was answered), the minimum and maximum values present in the survey results, 
the mean statistic with standard error, and standard deviation. P-values are included to compare mean levels of 
trust between the oncologist and primary care provider groups. T-tests were used to compare differences in trust 
between oncologist and PCP groups. Table 6 shows the average trust score by demographic group including 
gender, age range, residence origin, cancer site, and cancer stage. 
Table 3: Participant participation and survey completion  




Removed (COI) 1 
Completed 26 
Incomplete/Partial 6 
% Response 20.89% 
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Table 4: Variables for complete survey responses; patient characteristics and demographics 
Variable  (n)  (%) 
Race/ethnicity Non-Hispanic White 24 93% 
 American Indian/Alaska Native 1 4% 
 White/Other* 1 4% 
Marital Status    
 Single/Never Married 1 4% 
 Married 17 65% 
 Widow(er) 1 4% 
 Missing 7 27% 
Age (years)    
 ≤64 16 62% 
 ≥65 12 46% 
Gender    
 Male 9 35% 
 Female 17 65% 
Primary Cancer Site    
 Colon 20 77% 
 Rectal 6 23% 
Origin    
 Urban 18 69% 
 Rural 8 31% 
Qualitative Response    
 Yes 9 35% 
 No 17 65% 
Cancer Stage    
 0, I, II 7 27% 
 III, IV 19 73% 
Alcohol Consumption (current)    
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 Yes 7 27% 
 No 8 31% 
 Missing** 11 42% 
Smoking History (current)    
 Yes 1 4% 
 No 8 31% 
 Missing** 17 65% 
*Available survey response for participants who did not fit into any other racial categories 




Table 5: TiOS competency domains for the oncologist and primary care provider survey questions including means, medians, ranges, and 
P-values comparing domains 
Domain 
Oncologist PCP P = 
N Mean SD Median 
Min – 
Max N Mean SD Median Min – Max 
 
Global 26 3.65 0.60 4.00 2.00-4.00 26 2.96 0.97 3.00 1.00-4.00 0.003** 
Honesty 26 3.64 0.61 4.00 1.67-4.00 26 3.29 0.69 3.29 2.00-4.00 0.062* 
Competence 26 2.17 0.44 2.00 1.75-3.75 26 2.03 0.49 2.00 1.50-4.00 0.270 
Fidelity 26 3.66 0.40 3.80 2.80-4.00 26 3.21 0.72 3.10 2.00-4.00 0.007** 
Caring 26 2.82 0.42 2.75 2.25-4.00 26 2.50 0.54 2.38 1.50-4.00 0.022** 
*P< 0.1, ** P< 0.05 *** P< 0.01 
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Table 6: Mean trust score and P-values for Oncologists and Primary Care Providers by variable.  
Mean (SD) 
Demographic Group  Oncologist PCPs 
Age (years)    
 ≤64 3.65 (.65) 3.06 (.95) 
 ≥65 3.65 (.53) 2.80 (1.03) 
Gender    
 Male 3.89 (.33) 3.06 (1.01) 
 Female 3.53 (.67) 2.9 (.97) 
Primary Cancer Site    
 Colon 3.73 (.53) 2.93 (1.03) 
 Rectal 3.42 (.80) 3.08 (.80) 
Residence Status    
 Urban 3.69 (.60) 2.97 (1.06) 
 Rural 3.56 (.62) 2.94 (.78) 
Cancer Stage    
 0, I, II 3.57 (.61) 3.29 (.95) 
 III, IV 3.68(.61) 2.84 (.97) 
Alcohol Consumption (current)    
 Yes 4 (.00) 3.71 (.49) 
 No 3.44 (.68) 2.19 (.65) 
 
There was a difference observed between oncologist and primary care provider (PCP) trust levels for all 
domains (except Competence) with trust in the oncologist reported higher. The Global domain (P= 0.003) 
suggests that cancer patient in this population feel stronger overall levels of trust in their oncologist than their 
PCP. The Honesty domain (P= 0.062) suggests that patients feel that their oncologist is more likely to tell the 
truth and avoid intentional falsehoods than their PCP. The Fidelity domain (P= 0.007) suggests that patients feel 
that their oncologist has a stronger investment in the pursuit of their interests. The Caring domain (P= 0.022) 
suggests that cancer patients feel that their oncologist has more involvement in their care and is more sympathetic 
and devoted to them. Although no significant difference was observed in the Competence domain, it is interesting 
to note that the mean scores of trust for both the oncologist and PCP are neutral-to-low compared to the other 
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domain results. This may suggest that patients feel doubt in the medical skills of both their oncologist and PCP. 
Further studies should focus on understanding why patients feel these low levels of competence. 
Mean differences in the trust scores by patients’ demographic and clinical subgroups were observed 
within the oncologist group and the PCP group. For example, both in the oncologist and the PCP group, mean 
trust scores were higher among male than female patients, urban residents than rural residents, and patients who 
were diagnosed at later stages than those who were diagnosed at earlier stages Patients who stated that they 
currently consume alcohol reported higher trust in their oncologist (4.0) than those who do not currently consume 
alcohol (3.44). However, due to the small sample size, statistical tests were not conducted.  
Discussion & Future Recommendations 
 The results from this study showed a measurable difference in levels of trust between oncologist and 
primary care provider for colorectal cancer patients. The higher levels of trust reported for four out of five 
domains suggest that cancer patients feel more trust overall toward their oncologist than toward their PCP. The 
Global domain represents “the irreducible soul of trust, and includes aspects that combine elements from some or 
all of the separate dimensions” (Hillen et al., 2011). The difference in trust in the Global domain (P= 0.003) 
suggests that cancer patients feel a deeper trust in their oncologist that includes the aspects of Fidelity, Honesty, 
and Caring. The lack of trust felt toward both the oncologist and the PCP in the construct of Competence is an 
important result from this study. This suggests that although cancer patients feel higher levels of trust in their 
oncologist, they may not feel confident in the medical and interpersonal skills of their oncologist. Previous studies 
have found that Competence is part of the necessary foundation of trust in the patient-provider relationship 
(Hillen et al., 2011). It is also possible that severity of their disease may play a role in how cancer patients report 
trust (Salkeld et al., 2004). 
Future studies should seek to further understand the impact of trust in the patient-provider relationship as 
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well as the factors that influence trust. There was a group of individuals who refuse to respond to the survey 
instrument for this study. For future discussion, the medical data for this subset of the population should be 
examined to draw possible inferences for this behavior. A comparison of trust levels between patients with similar 
disease burden should be assessed to determine how much of an impact disease severity exerts on trust. 
Participant responses to the Trust in Oncologist Scale should be correlated with the length and quality of their 
provider relationship; this could also influence trust values. Additionally, there is a future opportunity to analyze 
qualitative data from similar cancer patient populations to gain a better understanding of trust in the patient-
provider relationship.  
One limitation of this study was that the study population displayed many of the same characteristics (for 
example: race and ethnicity) and was relatively small which constrained the analytical process. A larger study 
population would be required for a more thorough analysis. The lack of measurable difference between the 
variables could be due to the small sample size. Although this study collected the type of oncologist (medical or 
surgical), we did not compare trust results between these subgroups. A larger sample size and further research 
would be necessary to determine if there is a difference in trust reported within these oncology specialist 
subgroups. Due to the minimal use of the Trust in Oncologist Scale survey instrument, future studies should focus 
on cancer patients of all primary diagnoses. This study focused primarily on colon and rectal cancer, however, 
patients with other disease (for example: breast, prostate, leukemia) may have differing levels of trust due to the 
unique aspects of their individual disease burdens.  
The results from this study contribute to the growing body of knowledge regarding trust in the patient-
provider relationship. Previous studies have proposed that one way to promote trust in the patient-provider 
relationship is for the provider to demonstrate interpersonal and technical competence, moral comportment, and 
vigilance to support positive patient outcomes (Murray et al., 2014). We recommend a future focus on policies 
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that could be incorporated in the clinic setting to increase trust in the patient-provider relationship. These policies 
should place an emphasis on interpersonal competence for physicians as well as the importance that trust has on 
patient outcomes. Practice implications should also include an emphasis on creating higher-quality interactions 
between patients and their providers. A greater number of high-quality interactions in the clinic has previously 
been linked to higher levels of patient trust. To address the complications that population barriers may exert on 
this relationship, future studies should focus on measuring levels of trust in patient populations facing 
sociodemographic and geographic disparities.  
Limitations 
Limitations for this study included a small sample size that constrained data analysis. This limitation was 
addressed by submitting an IRB that allows ongoing recruitment of participants from the iCaRe2 database so that 
the study will not be limited to the current number of eligible participants. During analysis, it was important to 
remember the impact which diagnosis at a higher stage may have on patient-provider trust. This is an exploratory 
study to examine levels of trust between patients and their providers; therefore, statistical analysis was limited. 
Conclusions 
There is a need for this research in the state of Nebraska, as the levels of patient trust have not yet been 
studied within this oncology population. The Trust in Oncologist Scale has had minimal use since it was 
developed, despite its validated accuracy in cancer patient populations. Future studies should focus on conducting 
trust-based studies in cancer patients to better address the unique needs of this specific patient population. Higher 
levels of patient-provider trust are related to patient adherence of physician advice regarding treatment 
recommendations, increased behavioral changes, higher levels of screening practices, and avoidance of 
complementary medicine. The information gained from this study should further research among cancer patient 
populations and contribute to the greater body of knowledge regarding the impact of trust in patient care. 
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Administrative Resources 
It was necessary to have access to encrypted, file-protected computers on the UNMC campus for data 
collection and analysis. Basic office supplies such as envelopes, return envelopes, stamps, and printing supplies 
were required to mail out questionnaires. Fees for REDCap, SPSS software, and UNMC print shop and mailing 
services were also incurred.  
Ethics 
There are two risks for participants associated with this study: breach of privacy and psychosocial. It is 
possible that other people could learn the identity of participants. This risk was minimized by accessing personal 
health information (PHI) only on encrypted, UNMC secured network computers. There is a psychosocial risk as 
some participants may find talking about their cancer distressing. This risk was minimized by not requiring 
participants to answer survey questions that they may have found distressing. There was also a risk of conflict of 
interest as this study utilizes the iCaRe2 database that falls under portions of my employment responsibilities. This 
risk was mitigated as this study is outside of the scope of my job requirements and was conducted outside of 
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Service Learning/Capstone Experience Reflection 
Service Learning Activities:  
1.  Provide support for colorectal cancer related projects developed by Dr. Foster and collaborators 
2. Conduct chart reviews for study-related medical data  
3. Expand the study populations by consenting patients or adding posthumously  
4. Place orders for genetic mutation analysis and track patients through the process  
5. Build a master patient list for all patients who have received Cytoreductive Surgery (CRS). 
Service Learning Research Goals 
Contribute to the research projects currently being conducted by Jason Foster, M.D. in the department of 
Surgical Oncology. His clinical areas of expertise include management of peritoneal surface malignancies (PSMs) 
that spread in the abdominal cavity from an ovarian, colon, appendix, or mesothelioma primary. Treatment for 
these malignancies can involve cytoreductive surgery (CRS) - removal of visible tumor and intra-peritoneal 
hypothermic chemotherapy (HIPEC or IPHC) administered at the time of surgery (UNMC, 2018). Dr. Jason 
Foster is one of a very small number of surgical oncologists in the United States practicing HIPEC, which is used 
to treat these types of cancers.  
I have learned that UNMC functions as a trickle-down society with moderate (and occasionally non-
transparent) contact from senior leadership. Knowledge is disseminated through many channels of department 
leadership down through the employees and shared throughout.  The organization as a University is quite large and 
includes over 40 academic departments and 6 colleges. This size lends itself toward the formation of “silo” 
environments within each department. I am aware of several action plans in the process of being implemented to 
address this issue and break down these silos. As of 2016, there were over 5000 students and 4000 students with a 
multitude of new buildings and clinics in construction or newly built. Working in both the College of Public Health 
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and the Fred and Pamela Buffett Cancer Center (as a student and as an employee) has allowed me to observe the 
differences in how these departments function.  
During my time with this organization, I had the opportunity to observe several different types of leadership 
strategies and how these styles function. It was an important learning experience and allowed me to reflect on my 
own growing leadership style. Important leadership skills that I have observed include: 1) promoting a team-based 
atmosphere and 2) investing in the members of your team. Leaders who employ these skills are able to unify their 
departments and work toward shared goals. Those who do not possess these skills end up with employees who feel 
unappreciated or abandoned in their work efforts. Observing examples of both good and bad leadership styles 
throughout this experience has encouraged me to reflect upon my own abilities. In the future, this will enhance my 
ability to lead teams in a variety of disciplines.  
One specific type of leadership that I have observed recently is the ‘silent’ leader. This type of leadership is a 
more introverted approach to management in which power is exercised through actions rather than words. Leaders 
who possess this skill solve problems through collaboration, logical thought, and encouragement instead of through 
aggression or dominance. I have observed several silent leaders in the recent months and all have the same ability: 
they lead their teams through earned respect rather than force of character. This has affected how I think about my 
own leadership style in several ways. First, I have recognized that this style of leadership will not work well in every 
setting and with all types of employees. I also realize there are two major skills that silent leaders must develop to put 
this style into practice: 1) improved listening skills to encourage and consider multiple viewpoints of an issue and 2) 
leading by example without cutting corners. 
SL/CE activities that were performed for this project focused mainly on cancers of gastro-abdominal origin, 
which merged well with the study goals examining a colorectal cancer patient population. One of the main goals was 
to create a master database of all patients who had undergone CRS HIPEC procedures with Dr. Foster. The purpose 
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of creating this database was to provide a comprehensive foundation for both current and future research projects. 
Several current projects were discussed including: 
1. An assessment of the use of central lines in patients admitted for CRS HIPEC, specifically looking at 
outcome status, infection information, and dates of insertion/extraction. Results from this study will be used 
to establish surgical guidelines and policy changes within Nebraska Medicine.  
2. Publish a previously developed survey instrument into the REDCap software system to better capture 
responses for an ongoing study. This study is examining views of surgeons across the United States 
regarding their opinions on mortality rates for GI surgeries, including CRS HIPEC. 
3. Build the master database of CRS HIPEC patients. This was completed by creating a series of EPIC 
OneChart data reports for surgeries conducted by Dr. Foster during a period of time at Nebraska Medicine. 
The list was merged with a previous surgery list and is in the process of being updated for the following 
patient information: 
a. Patient demographics 
b. Surgery dates (accounting for the possibility of more than one CRS HIPEC 
c. Tumor type 
d. iCaRe2 enrollment status 
e. Dates of diagnosis, progression, recurrence, and events 
f. Therapies 
g. Outcome status 
h. Central line data 
Data for this list is being collected from the EPIC OneChart system through individual chart reviews. The 
master list, once complete, will require occasional updates as more patients are treated with the CRS HIPEC 
procedure. 
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4. Consenting patients into the iCaRe2 database registry for future research projects. Participants recruited into 
the registry were seen during routine standard of care visits with Dr. Foster. 
One of my greatest contributions during this SL/CE project period was the work for the master database. 
Completing this goal will allow Dr. Foster and his collaborators to pursue a multitude of future studies. A strength 
that I brought to this project was my previous knowledge and extensive training in chart review. I was able to 
immediately assist Dr. Foster with his projects due to my previous knowledge and experience in basic cancer 
etiology. These skills were due mainly to my on-the-job training as a clinical research coordinator with the Fred and 
Pamela Buffett Cancer Center, but also due in part to courses completed to fulfill the CEESP fellowship 
requirements. Another skill was my previous training and credentialing for patient study enrollment, which meant 
that only IRB regulatory change requirements were needed to begin work with his patient population. 
My views of public health research have been greatly changed by this experience. I recognize this 
opportunity to develop a working relationship with Dr. Foster that I would like to continue considering our shared 
research interests. I have learned a great deal about public health practice and how difficult it can be to conduct 
research with living participants, particularly those coping with a cancer diagnosis. I value this entire experience, all 
that I have learned, and everyone with whom I have had the pleasure of working. 
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Appendices 
iCaRe2 Core Data Questionnaire *See separate document 
iCaRe2 GACCare Extended Module Questionnaire *See separate document 
TiOS Survey Instrument *See separate document 
Qualitative Data 
An interesting component to this study was the qualitative data produced by the open-ended question at 
the end of the survey allowing patients to comment with any additional information pertinent to their opinions. 
The initial data collection produced seven qualitative responses, of which four commented on the relationship 
between the patient and receiving care from multiple doctors. Three of the seven had positive interactions with 
their providers and received coordinated care between their oncologists and primary care physicians; others 
reported coordinated care between multiple oncology providers. 
“My primary doctor is in Missouri, as does my oncologist. He [PCP] found Dr. [***] to treat me, have surgery, and 
now I have two oncologists conferring back and forth. They all have been excellent.”  
 
“I am very thankful for having both doctors. The combination of care they provided saved my life.” 
 
“Dr. Armitage sent me to see [***] as soon as he found out I had colon cancer. They both saved my life!” 
 
These comments relate to the previously established relationship between the quality of care interactions 
and levels of patient-provider trust. It suggests a possible relationship between trust and the multidisciplinary 
approach to cancer care. Further qualitative analysis would be necessary. 
IRB Statement of Approval 
Research for this study was approved by the Institutional Review Board (IRB) at the University of Nebraska 
Medical Center under IRB # 010-18-EP. 
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Application of Public Health Competencies 
*See separate document 
